INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Lobbying registrant
JA

JEFFREY J. KIMBELL & ASSOCIATES, INC.

Open in network
Disclosed transactions0
Buys / sells0 / 0
Max Insider Score—
Connections20with evidence

Disclosed transactions

No records

No transactions recorded for this profile.

Verified connections

  • Lobbied forevidence
    STERIS plcLDA Q2 2026 second quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    Brookdale Senior Living Inc.LDA Q2 2026 second quarter · Health issues, HOU · Aug 26, 2026
  • Lobbied forevidence
    Atara Biotherapeutics, Inc.LDA RR 2026 second quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    Atea Pharmaceuticals, Inc.LDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    MANNKIND CORPLDA Q2 2026 second quarter · Medicare/Medicaid, Health issues, Defense · Aug 26, 2026
  • Lobbied forevidence
    ILLUMINA, INC.LDA Q2 2026 second quarter · Health issues, Budget/appropriations · Aug 26, 2026
  • Lobbied forevidence
    Organon & Co.LDA Q1 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    Opus Genetics, Inc.LDA Q2 2026 second quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    INSMED IncLDA Q2 2026 second quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    ACME UNITED CORPLDA Q1 2026 first quarter · Health issues, Trade · Aug 26, 2026
  • Lobbied forevidence
    ACCURAY INCLDA Q2 2026 second quarter · Trade, Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    HARROW, INC.LDA Q2 2026 second quarter · Medicare/Medicaid, Health issues · Aug 26, 2026
  • Lobbied forevidence
    COLLEGIUM PHARMACEUTICAL, INCLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    GILEAD SCIENCES, INC.LDA Q2 2026 second quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    AMGEN INCLDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    Phathom Pharmaceuticals, Inc.LDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    AGIOS PHARMACEUTICALS, INC.LDA Q1 2026 first quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    AVITA Medical, Inc.LDA 1T 2026 first quarter · Health issues, Medicare/Medicaid · Aug 26, 2026
  • Lobbied forevidence
    Axogen, Inc.LDA 1T 2026 first quarter · Health issues · Aug 26, 2026
  • Lobbied forevidence
    ARDELYX, INC.LDA Q1 2026 first quarter · Medicare/Medicaid, Health issues · Aug 26, 2026